Copeptin and the prognosis of patients with coronary artery disease: a meta-analysis

被引:0
作者
Zhewei Shi
Caizhen Qian
机构
[1] Zhuji Affiliated Hospital of Wenzhou Medical University,Department of Cardiology
来源
Irish Journal of Medical Science (1971 -) | 2023年 / 192卷
关键词
Copeptin; Coronary artery disease; Major adverse cardiovascular events; Meta-analysis; Mortality;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2129 / 2141
页数:12
相关论文
共 244 条
[1]  
Libby P(2005)Pathophysiology of coronary artery disease Circulation 111 3481-3488
[2]  
Theroux P(2019)A review on coronary artery disease, its risk factors, and therapeutics J Cell Physiol 234 16812-16823
[3]  
Malakar AK(2020)Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association Circulation 141 e779-e806
[4]  
Choudhury D(2020)Evidence in guidelines for treatment of coronary artery disease Adv Exp Med Biol 1177 37-73
[5]  
Halder B(2022)Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990–2019 Eur J Prev Cardiol 29 420-431
[6]  
Paul P(2022)Heart disease and stroke statistics-2022 update: a report from the American Heart Association Circulation 145 e153-e639
[7]  
Uddin A(2020)Novel biomarkers in the prognosis of patients with atherosclerotic coronary artery disease Rev Port Cardiol (Engl Ed) 39 667-672
[8]  
Chakraborty S(2022)Copeptin in fluid disorders and stress Clin Chim Acta 529 46-60
[9]  
Arnold SV(2019)Copeptin — a new diagnostic and prognostic biomarker in neurological and cardiovascular diseases Neuro Endocrinol Lett 40 207-214
[10]  
Bhatt DL(2022)Copeptin as a diagnostic and prognostic biomarker in cardiovascular diseases Front Cardiovasc Med 9 2096-2106